Quick Answer: GIP and GLP-1 are incretin hormones produced in the small intestine that enhance glucose-dependent insulin secretion and regulate metabolism
Recommended for patients with specific deficiencies or those already working with a Saffron & Sage practitioner
A thorough discussion with a medical professional will confirm if any aspect of your health history makes this treatment inappropriate for you
Among participants without diabetes, cardiovascular risk reduction was consistent across all baseline HbA1c subgroups (less than 5.7%, 5.7% to 6.0%, and 6.0% to 6.5%) and across categories of HbA1c change from baseline to 20 weeks
A 500mg jump in dose won't overcome a caloric surplus
Clinicians prescribing BPC-157 off-label do so based on preclinical data, mechanistic plausibility, and patient-reported outcomes, not a regulatory evidence package